Printer Friendly

Articles from M2 Pharma (July 16, 2019)

1-28 out of 28 article(s)
Title Author Type Words
Abbott wins US FDA approval of next-generation MitraClip under its leading MitraClip platform. 282
AstraZeneca provides update on decision by US FDA for Farxiga in type-1 diabetes. 248
Bayer wins US FDA approval for Gadato to assess myocardial perfusion and late gadolinium enhancement in adult patients with CAD. 278
Boehringer Ingelheim Acquires Swiss Biotechnology Firm AMAL Therapeutics. 464
Dicerna Receives Breakthrough Therapy Designation for DCR-PHXC for Treatment of Primary Hyperoxaluria Type 1. 683
EMMAC acquires 100% of Terra Verde with the oldest cannabis cultivation licence in Portugal. 248
ESSA Pharma names new chief medical officer. 256
Exelixis Updates Phase 1b COSMIC-021 Trial of Cabozantinib in Combination with Atezolizumab in Patients with Advanced Solid Tumors. 1007
Genomma Lab Internacional receives Sanitary License from Mexican health commission. 163
Gilead and Galapagos Enter 10-Year Research and Development Collaboration. 985
Gilead Sciences signs 10-year global research and development collaboration with Galapagos. 192
Johnson & Johnson declares dividend of USD0.95 per share for Q3 2019. 136
Magenta Therapeutics Appoints Anne McGeorge to Board of Directors. 266
Medical Coaches to produce mobile opioid clinics in Colorado. 226
MSN Labs/Novadoz Pharmaceuticals announces US FDA approval of Abiraterone. 156
Navitor Names James Randall Owen as Chief Medical Officer. 662
New Immune Data from Ongoing ADXS-NEO Phase 1 Study Support Clinical Potential for Neoantigen-Directed Immunotherapies. 903
Novian Health passes CE Mark for groundbreaking laser Novilase Breast Therapy. 230
Orphazyme appoints new CEO. 203
Propanc Biopharma Provides Update on Preparation of PRP for Clinical Trial Application Submission and Recently Completed Reverse Stock Split. 376
Propanc Biopharma provides update on PRP clinical trial application and reverse common stock split. 254
RaySearch and Vision RT to work together on technology development projects under strategic partnership. 213
Recursion Pharmaceuticals Secures USD 121m in Series C Financing. 306
Sosei Heptares signs research collaboration and license agreement with Genentech to discover and develop novel medicines. 206
Sun Pharmaceutical's Ezallor Sprinkle capsules launched in US. 191
Synlogic Reports Positive Top-line Data from Phase 1/2a Study of SYNB1618 in Patients with Phenylketonuria and Guides to Next Phase of Development. Clinical report 527
University of California awarded US CRISPR-Cas9 patent related to production of genetically modified cells. 216
US FDA grants investigational new drug approval for Sensorion to proceed with SENS-401. 146

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters